Health Catalyst (HCAT) Gains from Investment Securities (2018 - 2025)

Health Catalyst's Gains from Investment Securities history runs 6 years deep, the most recent figure standing at -$1.9 million for Q3 2025.

• Quarterly Gains from Investment Securities fell 15.41% year-over-year to -$1.9 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$3.5 million (down 115.41% YoY) and the FY2025 annual result came in at -$7.1 million, down 330.15% from the prior year.
• Gains from Investment Securities was -$1.9 million for Q3 2025 at Health Catalyst, down from -$1.6 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $6.9 million in Q2 2021 and bottomed at -$8.4 million in Q1 2022.
• A 4-year average of $1.3 million and a median of $2.2 million in 2021 frame the typical range for Gains from Investment Securities.
• Annual changes were most pronounced in 2021 — Gains from Investment Securities surged 714.01% — and 2022, when it tumbled 490.72%.
• Health Catalyst's Gains from Investment Securities stood at $6.4 million in 2021, then slumped by 58.71% to $2.6 million in 2022, then slumped by 162.31% to -$1.6 million in 2024, then slipped by 15.41% to -$1.9 million in 2025.
• Business Quant data shows HCAT's Gains from Investment Securities at -$1.9 million in Q3 2025, -$1.6 million in Q3 2024, and $2.6 million in Q3 2022.